Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets NEW YORK, July 16, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024.The employer, a leader in environmental services, selected Dario' ...